Ian Megson

Professor Ian Megson is the Head of Health Research and Innovation at the University of the Highlands and Islands. He holds a Professorship in the Department of Diabetes and Cardiovascular Science, with affiliations to the Highland Diabetes Institute and The Centre for Health Science. His research focuses on oxidative stress, inflammation, free radicals, and their roles in cardiovascular disease and diabetes. He has pioneered studies on nitric oxide donor drugs, nanoparticle toxicity, and antioxidant mechanisms. Megson has secured significant grant funding and published widely, with over 167 publications and an h-index of 54. He is a Fellow of the Higher Education Academy and Society of Biology.

• Education: BSc in Physiology (University of St Andrews), PhD in Nitric Oxide Research (University of St Andrews).
• Research Interests: Free radicals, cardiovascular disease mechanisms, diabetes complications, nanoparticle toxicity, and antioxidant therapies.

His recent work includes studies on graphene oxide inhalation effects, lipid emulsion drug interactions, and UV-LED activated photocatalytic wastewater treatment. Megson has led collaborations across cardiology, toxicology, and environmental health, emphasizing translational research.

• Awards: Recognized for contributions to cardiovascular science and academic leadership.
• Grants/Projects: Multiple grants supporting research on oxidative stress, nanoparticle toxicity, and clinical trials.

Megson’s lab focuses on exosomal diagnostics for cardiovascular diseases and developing novel therapies against diabetic complications. He collaborates globally, prioritizing clinical translation of basic science findings.